Get Started

SION

NASD Sionna Therapeutics, Inc.
Nov 5, 2026 · 7:34 AM ET LAST TRADE Market Closed

$3.79 ↑ +0.06 (+1.49%) Trading Up from the previous close of $3.73

YTD change
-90.80%
vs 20-day SMA
-6.46%
vs 200-day SMA
-87.20%

Price ranges

Previous day
$3.52 $3.84
open $3.72 close $3.73
+$0.01 (+0.27%)
Today
$0.00 $0.00
$3.79
Past week
$3.52 $4.16
from $4.04 now $3.79
-$0.25 (-6.30%)
Past month
$3.52 $5.12
from $4.82 now $3.79
-$1.03 (-21.46%)
This year
$3.52 $54.97
from $41.14 now $3.79
-$37.35 (-90.80%)

Price & Performance

-37.24 (-90.90%) / 6M

$-0.1952$18.15$36.49$54.84May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 93.1% away from all-time highs of $54.97
  • SION is down 91% since the beginning of the year
  • SION is down 89% over the past 12 months
  • SION is down 21% over the past 1 month
  • 14% of all SION investors are betting against SION

SION reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -89.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.66
Earnings momentum -3.6% Quarterly EPS growth
Quarterly change -3.6%

Valuation

P/E ratio N/A
Enterprise value $-34556300.0
Beta 1.22

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$211.0M
Debt$8.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $171.1M

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.99 +0.61%
JNJ Johnson & Johnson $276.32 +3.81%
ABBV AbbVie, Inc. $294.83 +3.09%
MRK Merck & Co., Inc. $150.36 +3.93%
RHHBY Roche Holding Ltd Sponsored ADR $60.94 +2.97%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.